Skip to Content

Join the 'Lysosomal Acid Lipase Deficiency' group to help and get support from people like you.

Lysosomal Acid Lipase Deficiency News

Related terms: Wolman's Disease

Newborn Screening Tests Approved

Posted 6 Feb 2017 by Drugs.com

MONDAY, Feb. 6, 2017 – A set of screening tests designed to detect four rare metabolic disorders in newborns has been approved by the U.S. Food and Drug Administration. The "Seeker" system of diagnostics is designed to screen for Mucopolysaccharidosis Type 1, Pompe, Gaucher and Fabry. These are the first tests approved to screen for the inherited disorders, which affect proteins that normally ...

Kanuma Approved for Rare Missing-Enzyme Disease

Posted 12 Dec 2015 by Drugs.com

TUESDAY, Dec. 8, 2015 – Kanuma (sebelipase alfa) has been approved by the U.S. Food and Drug Administration as the first treatment for a rare but often-deadly disease caused by an enzyme deficiency. People with Lal deficiency, also known as Wolman disease or cholesteryl ester storage disease, produce little or none of the enzyme lysosomal acid lipase (Lal). This causes fat buildup in the body ...

Ask a Question

Further Information

Related Drug Support Groups

sebelipase alfa, Kanuma